Warning Letter — Bharat Overseas Inc.
The FDA issued a Warning Letter to Bharat Overseas Inc. following an investigation by the Office of Inspections and Investigations.
This notice affects Bharat Overseas Inc. and may impact personnel responsible for facility compliance, quality assurance, and regulatory filings within the organization.
A Warning Letter from the Office of Inspections and Investigations signifies that the agency has identified significant violations of FDA regulations. This action suggests that previous facility inspections or investigations revealed non-compliance that requires formal corrective action to avoid further enforcement measures, such as seizures or injunctions.
Regulatory and QA departments should review current facility registration status and ensure all food safety documentation is current. Firms should conduct internal audits of facility compliance ahead of potential Office of Inspections and Investigations oversight.
FDA Warning Letter issued to: Bharat Overseas Inc.. 05/14/2026 — Office of Inspections and Investigations. Source: https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/bharat-overseas-inc-729199-05142026
Open in openFDA / FDA.gov